ArticleCancers2022

Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen.

Jiujun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.